4 results
8-K
EX-99.2
MCRB
Seres Therapeutics Inc
10 Aug 20
Regulation FD Disclosure
7:31am
to be manufactured in accordance with Good Manufacturing Practice conditions using stringent standards to ensure product quality and consistency. To support product … safety, Seres utilizes a unique manufacturing process that inactivates numerous potential pathogens, including species of non-spore bacteria
8-K
EX-99.1
MCRB
Seres Therapeutics Inc
7 May 20
Seres Therapeutics Reports First Quarter 2020 Financial Results and Provides Business Updates
7:00am
Manufacturing Practices (GMP) conditions using stringent standards to ensure product quality and consistency. To maximize product safety, Seres utilizes
- Prev
- 1
- Next